HESTA has pledged to support equitable access to COVID-19 vaccines globally and has committed to investment approaches that will support the push for greater vaccine access.
The industry superannuation fund said uneven vaccination rates posed a risk to global health and economic activity in 2021, leading it to sign an investor statement pushing for urgent G7 and G20 governments to take action.
HESTA chief executive, Debby Blakey, said a successful and equitable global distribution of vaccines would have an impact on the pact of economic recovery, and therefore HESTA members’ investments.
HESTA pointed to a study by the International Chamber of Commerce Research Foundation that found the global economy stood to lose as much as US$9.2 trillion ($11.6 trillion) if the COVID-19 vaccines are not widely available in developing countries.
“Ensuring developing economies have equal access to COVID-19 vaccines, medicines and tests will reduce the impact of COVID-19 worldwide, and help foster a fairer and more sustainable global recovery,” Blakey said.
“We’re keen to work with other global investors to explore ways we can encourage further investment that will help fund vaccine distribution.”
A “concerning” number of Aussies don’t know what they pay in super fees, a young super fund has said.
The corporate regulator has shared some ‘disappointing’ findings upon reviewing the public communications of more than 20 trustees with regards to death benefits.
According to the industry body, funds should have an obligation to transfer members in failing products to better-performing products in a timely way.
The $9 billion fund is backing agriculture investor GO.FARM, with its capital already directed towards enhancing two key assets.
Add new comment